Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Novel Target Genes and Epigenetic Pathways Involved in High Risk Acute Lymphoblastic Leukemia

Sara Deola, Dhanya Kizhakayil, Sheanna M Herrera, Muhammad Elnaggar, MDPhD, Che-Ann Lachica, Giusy Gentilcore, PhD, Ayman Saleh, MD, Anila Ejaz, MD, Zehra Fadoo, MBBS, MD, Kulsoom Ghias, PhD, Irene Pusceddu, PhD, Irene M Cavattoni, Ramzi Temanni, PhD, Najeeb A Syed, M.Tech, Fazulur R Vempalli, M.Bioinformatics, Patrizia Comoli, MD, Tommaso Mina, MD, Chiara Cugno, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141227

Published: 2020

Journal Articles

HHV-6 Infection/Reactivation after Allogeneic Stem Cell Transplantation in Pediatric Patients: Epidemiology, Risk Factors and Outcome

Francesca Compagno, MD, Stella Boghen, MD, Sabrina Basso, PhD, Antonella Gurrado, PhD, Alessandra Maiello, PhD, Laura Catenacci, PhD, Tommaso Mina, MD, Santina Recupero, MD, Alessandra Tolva, MD, Elena Bergami, MD, Patrizia Comoli, MD, Marco Zecca, MD

Blood (2018) 132 (Supplement 1): 3362.

https://doi.org/10.1182/blood-2018-99-116386

Published: 2018

Journal Articles

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Franco Locatelli, MD, Maria Ester Bernardo, MD, Alice Bertaina, MD PhD, Carla Rognoni, PhD, Patrizia Comoli, MD, Attilio Rovelli, MD, Andrea Pession, MD PhD, Franca Fagioli, MD, Claudio Favre, MD, Edoardo Lanino, MD, Giovanna Giorgiani, MD, Pietro Merli, MD, Arcangelo Prete, MD, Marco Zecca, MD

Blood (2016) 128 (22): 1168.

https://doi.org/10.1182/blood.V128.22.1168.1168

Published: 2016

Journal Articles

Evidence for CD19+ (B) CD8+ (T)-Cell Interactions in Blood and Tissues from Patients with Graft-Versus-Host Disease

Sara Deola, MDPhD, Chiara Cugno, MD, Patrizia Comoli, MD, Ilaria Guido, MSc, Laura Rubert, MD, Marco Zecca, MD, Diego Zanolini, PhD, Antonia Follenzi, MDPhD, Martin Langes, Giovanni Negri, MD, Martina Tauber, MD, Irene Pusceddu, MSc, Irene Cavattoni, MD, Mirija Svaldi, MD, Ena Wang, MD, Sergio Rutella, MDPhD, Francesco M Marincola, MD

Blood (2015) 126 (23): 4287.

https://doi.org/10.1182/blood.V126.23.4287.4287

Published: 2015

Journal Articles

Intrabone Injection of T-Cell Depleted Peripheral Blood Stem Cells from HLA-Haploidentical Donors to Reduce the Risk of Graft Rejection in Children

Luisa Strocchio, MD, Marco Zecca, MD, Patrizia Comoli, MD, Perotti Cesare, MD, Claudia Del Fante, MD, Laura Rubert, MD, Elena Bergami, MD, Francesca Introzzi, MD, Alessandra Tolva, MD, Gianluca Viarengo, MD, Franco Locatelli

Blood (2014) 124 (21): 1146.

https://doi.org/10.1182/blood.V124.21.1146.1146

Published: 2014

Journal Articles

Protective T-Cell Responses to Several Recombinant Aspergillus Antigens May Be Detected Since the Onset of the Infection in Patients with Invasive Aspergillosis, and May Be Exploited for Therapeutic Purposes,

Blood (2011) 118 (21): 3229.

https://doi.org/10.1182/blood.V118.21.3229.3229

Published: 2011

Journal Articles

Adenovirus Specific T-Cell Lines Devoid of Alloreactivity Against Haploidentical Recipients Can Be Obtained Using a Set of Adenovirus Hexon Peptides.

Patrizia Comoli, MD, Marco W. Schilham, PhD, Sabrina Basso, PhD, Tamara van Vreeswijk, Rita Maccario, PhD, Maarten J.D. van Tol, PhD, Franco Locatelli, MD, PhD, Louise A. Veltrop-Duits, PhD

Blood (2007) 110 (11): 3273.

https://doi.org/10.1182/blood.V110.11.3273.3273

Published: 2007

Journal Articles

Human Mesenchymal Stem Cells Inhibit In Vitro Antibody Production Against Alloantigens.

Patrizia Comoli, MD, Rita Maccario, PhD, Maria Antonietta Avanzini, PhD, Fabrizio Ginevri, MD, Antonia Moretta, PhD, Marina Podestà, PhD, Massimo Marconi, PhD, Angela Cometa, BSci, Maria Ester Bernardo, MD, Francesco Frassoni, MD, Franco Locatelli, MD, PhD

Blood (2005) 106 (11): 3033.

https://doi.org/10.1182/blood.V106.11.3033.3033

Published: 2005

Journal Articles

Successful In Vitro Priming of EBV-Specific CD8+ T Cells Endowed with Strong Cytotoxic Function for Prophylaxis or Treatment of PTLD in EBV Seronegative Hosts.

Patrizia Comoli, MD, Franco Locatelli, MD, Ph.D, Chiara Frasson, BSci, Sabrina Basso, Ph.D, Massimo Labirio, BSci, Antonia Moretta, Ph.D, Daniela Montagna, Ph.D, Fabrizio Ginevri, MD, Rita Maccario, Ph.D

Blood (2005) 106 (11): 1480.

https://doi.org/10.1182/blood.V106.11.1480.1480

Published: 2005

NARROW

Novel Target Genes and Epigenetic Pathways Involved in High Risk Acute Lymphoblastic Leukemia

HHV-6 Infection/Reactivation after Allogeneic Stem Cell Transplantation in Pediatric Patients: Epidemiology, Risk Factors and Outcome

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Evidence for CD19+ (B) CD8+ (T)-Cell Interactions in Blood and Tissues from Patients with Graft-Versus-Host Disease

Intrabone Injection of T-Cell Depleted Peripheral Blood Stem Cells from HLA-Haploidentical Donors to Reduce the Risk of Graft Rejection in Children

Protective T-Cell Responses to Several Recombinant Aspergillus Antigens May Be Detected Since the Onset of the Infection in Patients with Invasive Aspergillosis, and May Be Exploited for Therapeutic Purposes,

Adenovirus Specific T-Cell Lines Devoid of Alloreactivity Against Haploidentical Recipients Can Be Obtained Using a Set of Adenovirus Hexon Peptides.

Human Mesenchymal Stem Cells Inhibit In Vitro Antibody Production Against Alloantigens.

Successful In Vitro Priming of EBV-Specific CD8+ T Cells Endowed with Strong Cytotoxic Function for Prophylaxis or Treatment of PTLD in EBV Seronegative Hosts.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only